241 related articles for article (PubMed ID: 10923037)
21. Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.
Song E; Luo N; Alvarado JA; Lim M; Walnuss C; Neely D; Spandau D; Ghaffarieh A; Sun Y
Sci Rep; 2017 May; 7(1):1442. PubMed ID: 28473699
[TBL] [Abstract][Full Text] [Related]
22. A novel interstitial deletion in Xq25, identified by array-CGH in a patient with Lowe syndrome.
Addis M; Meloni C; Congiu R; Santaniello S; Emma F; Zuffardi O; Ciccone R; Cao A; Melis MA; Cau M
Eur J Med Genet; 2007; 50(1):79-84. PubMed ID: 17142121
[TBL] [Abstract][Full Text] [Related]
23. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
[TBL] [Abstract][Full Text] [Related]
24. [Clinical findings in a patient with Lowe syndrome and a splice site mutation in the OCRL1 gene].
Keilhauer CN; Gal A; Sold JE; Zimmermann J; Netzer KO; Schramm L
Klin Monbl Augenheilkd; 2007 Mar; 224(3):207-9. PubMed ID: 17385124
[TBL] [Abstract][Full Text] [Related]
25. [Investigation and OCRL mutation analysis of a family with oculocerebrorenal syndrome of Lowe].
Shi RM; Bian XH; Li LM; Liu XH
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):366-9. PubMed ID: 24750831
[TBL] [Abstract][Full Text] [Related]
26. [Oculo-cerebro-renal Lowe syndrome: clinical, biochemical and molecular studies in a Moroccan patient].
Chabaâ L; Monnier N; Dahri S; Jorio M; Lunardi J; Chabraoui L
Ann Biol Clin (Paris); 2006; 64(1):53-9. PubMed ID: 16420990
[TBL] [Abstract][Full Text] [Related]
27. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.
Jänne PA; Suchy SF; Bernard D; MacDonald M; Crawley J; Grinberg A; Wynshaw-Boris A; Westphal H; Nussbaum RL
J Clin Invest; 1998 May; 101(10):2042-53. PubMed ID: 9593760
[TBL] [Abstract][Full Text] [Related]
28. Identification of two novel mutations in the OCRL1 gene in two Chinese families with Lowe syndrome.
Ke YH; He JW; Fu WZ; Zhang ZL
Nephrology (Carlton); 2012 Jan; 17(1):20-5. PubMed ID: 21854507
[TBL] [Abstract][Full Text] [Related]
29. Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome.
Bothwell SP; Farber LW; Hoagland A; Nussbaum RL
Mamm Genome; 2010 Oct; 21(9-10):458-66. PubMed ID: 20872266
[TBL] [Abstract][Full Text] [Related]
30. Whole-genome sequencing revealed an interstitial deletion encompassing OCRL and SMARCA1 gene in a patient with Lowe syndrome.
Zheng B; Chen Q; Wang C; Zhou W; Chen Y; Ding G; Jia Z; Zhang A; Huang S
Mol Genet Genomic Med; 2019 Sep; 7(9):e876. PubMed ID: 31376231
[TBL] [Abstract][Full Text] [Related]
31. Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome.
Nakano E; Yoshida A; Miyama Y; Yabuuchi T; Kajiho Y; Kanda S; Miura K; Oka A; Harita Y
J Hum Genet; 2020 Oct; 65(10):831-839. PubMed ID: 32427950
[TBL] [Abstract][Full Text] [Related]
32. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe.
Leahey AM; Charnas LR; Nussbaum RL
Hum Mol Genet; 1993 Apr; 2(4):461-3. PubMed ID: 8504307
[TBL] [Abstract][Full Text] [Related]
33. Genotype Phenotype Correlation in Dent Disease 2 and Review of the Literature:
Gianesello L; Arroyo J; Del Prete D; Priante G; Ceol M; Harris PC; Lieske JC; Anglani F
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680992
[TBL] [Abstract][Full Text] [Related]
34. Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.
Recker F; Zaniew M; Böckenhauer D; Miglietti N; Bökenkamp A; Moczulska A; Rogowska-Kalisz A; Laube G; Said-Conti V; Kasap-Demir B; Niemirska A; Litwin M; Siteń G; Chrzanowska KH; Krajewska-Walasek M; Sethi SK; Tasic V; Anglani F; Addis M; Wasilewska A; Szczepańska M; Pawlaczyk K; Sikora P; Ludwig M
Pediatr Nephrol; 2015 Jun; 30(6):931-43. PubMed ID: 25480730
[TBL] [Abstract][Full Text] [Related]
35. Oculocerebrorenal syndrome of Lowe: three mutations in the OCRL1 gene derived from three patients with different phenotypes.
Kawano T; Indo Y; Nakazato H; Shimadzu M; Matsuda I
Am J Med Genet; 1998 Jun; 77(5):348-55. PubMed ID: 9632163
[TBL] [Abstract][Full Text] [Related]
36. A novel and de novo deletion in the OCRL1 gene associated with a severe form of Lowe syndrome.
Peces R; Peces C; de Sousa E; Vega C; Selgas R; Nevado J
Int Urol Nephrol; 2013 Dec; 45(6):1767-71. PubMed ID: 22821049
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel deletion of the entire OCRL1 gene detected by FISH analysis in a family with Lowe syndrome.
Peverall J; Edkins E; Goldblatt J; Murch A
Clin Genet; 2000 Dec; 58(6):479-82. PubMed ID: 11149618
[TBL] [Abstract][Full Text] [Related]
38. The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function.
Lichter-Konecki U; Farber LW; Cronin JS; Suchy SF; Nussbaum RL
Mol Genet Metab; 2006; 89(1-2):121-8. PubMed ID: 16777452
[TBL] [Abstract][Full Text] [Related]
39. Physical mapping and genomic structure of the Lowe syndrome gene OCRL1.
Nussbaum RL; Orrison BM; Jänne PA; Charnas L; Chinault AC
Hum Genet; 1997 Feb; 99(2):145-50. PubMed ID: 9048911
[TBL] [Abstract][Full Text] [Related]
40. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.
Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T
CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
